MedTrace Logo

Studying Heart Ablation After Left Atrial Closure in High-Bleeding-Risk Atrial Fibrillation Patients

NCT07580937 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 198

Last updated 2026-05-12

No results posted yet for this study

Summary

The purpose of this multicenter study is to collect information from routine clinical practices for patients with left atrial appendage occlusion (LAAO) devices presenting for pulmonary vein isolation (PVI) or left atrial ablation. Assessment will include characterization of patient characteristics, procedural details, management of post-procedure anticoagulation, and clinical outcomes.

Conditions

Interventions

OTHER

Data collection

Data collection on patient characteristics and comorbidities, baseline echocardiographic data, home medications including oral anticoagulation regimen, ablation data, left atrial appendage occlusion device data, and complication-related details from routine procedures and encounters

Sponsors & Collaborators

  • Rush University

    collaborator OTHER

  • University of Chicago

    lead OTHER

Principal Investigators

  • Henry Huang, MD · University of Chicago

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-08
Primary Completion
2024-12-10
Completion
2026-03-30

Countries

  • United States
  • Belgium
  • China
  • France
  • Germany
  • Italy
  • Singapore
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07580937 on ClinicalTrials.gov